Jan 16 (Reuters) - Centrexion Therapeutics:
* CENTREXION THERAPEUTICS ANNOUNCES FAST TRACK DESIGNATION GRANTED BY FDA TO CNTX-4975 FOR TREATMENT OF KNEE OSTEOARTHRITIS PAIN Source text for Eikon:
 